➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Baxter
Mallinckrodt
Moodys
Dow

Last Updated: September 26, 2021

DrugPatentWatch Database Preview

Santen Company Profile


Email this page to a colleague

« Back to Dashboard

Summary for Santen
International Patents:94
US Patents:6
Tradenames:4
Ingredients:3
NDAs:4

Drugs and US Patents for Santen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Santen VERKAZIA cyclosporine EMULSION;OPHTHALMIC 214965-001 Jun 23, 2021 RX Yes Yes 9,956,289 ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Santen QUIXIN levofloxacin SOLUTION/DROPS;OPHTHALMIC 021199-001 Aug 18, 2000 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial
Santen VERKAZIA cyclosporine EMULSION;OPHTHALMIC 214965-001 Jun 23, 2021 RX Yes Yes 9,132,071 ⤷  Free Forever Trial Y ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Santen

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Santen ALAMAST pemirolast potassium SOLUTION/DROPS;OPHTHALMIC 021079-001 Sep 24, 1999 5,034,230*PED ⤷  Free Forever Trial
Santen QUIXIN levofloxacin SOLUTION/DROPS;OPHTHALMIC 021199-001 Aug 18, 2000 5,053,407 ⤷  Free Forever Trial
Santen QUIXIN levofloxacin SOLUTION/DROPS;OPHTHALMIC 021199-001 Aug 18, 2000 4,551,456 ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for Santen Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2049079 PA2017003,C2049079 Lithuania ⤷  Free Forever Trial PRODUCT NAME: CIKLOSPORINAS; REGISTRATION NO/DATE: EU/1/15/990 20170319
1809237 C01809237/01 Switzerland ⤷  Free Forever Trial PRODUCT NAME: CICLOSPORIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66093 08.09.2016
1809237 300741 Netherlands ⤷  Free Forever Trial PRODUCT NAME: CICLOSPORINE (EYE DROP EMULSION); REGISTRATION NO/DATE: EU/1/15/990 20150323
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Boehringer Ingelheim
Harvard Business School
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.